Management of Elevated Lipid Profiles

Assessment and Treatment Goals

The American Diabetes Association recommends reducing triglycerides to <150 mg/dL as the primary goal, and reducing LDL cholesterol to <100 mg/dL as the secondary goal, with the tertiary goal of maintaining HDL cholesterol >40 mg/dL 1, 2
For patients with elevated triglycerides and LDL cholesterol, the initial assessment should include total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, with target values of <200 mg/dL, <100 mg/dL, ≥40 mg/dL, and <150 mg/dL, respectively 1, 2

The American Academy of Family Physicians recommends weight reduction and dietary counseling as the foundation of treatment, with a focus on reducing intake of simple carbohydrates and increasing physical activity 1, 3
Limiting alcohol consumption is also recommended, as it can significantly raise triglyceride levels 3
Fenofibrate is the first-line pharmacological treatment for elevated triglycerides, with a dosage of 54-160 mg once daily, and has demonstrated efficacy in reducing triglycerides by 35-54% in clinical trials 1, 5
Statins may be considered for elevated LDL cholesterol, with modest triglyceride-lowering effects of 10-15%, and combination therapy may be considered if both LDL and triglycerides remain elevated after initial therapy 1, 3, 7, 2

The American Diabetes Association recommends rechecking the lipid panel after 6-12 weeks of therapy, and monitoring for potential side effects of fibrates, including myositis, liver function abnormalities, and gallstones 2, 7
Adjusting therapy based on response and tolerability is also recommended, with consideration of combination therapy with statins and fibrates, which increases the risk of myositis 2, 6, 7

The European Heart Journal recommends that if combination therapy is necessary, fenofibrate is preferred over gemfibrozil when used with statins, and that fibrates and statins should be taken at different times of day to minimize the risk of myopathy 4, 6
The American Academy of Family Physicians also recommends addressing underlying causes of hypertriglyceridemia, such as alcohol consumption, poorly controlled diabetes, and certain medications, and initiating pharmacological therapy only after adequate lifestyle modification attempts 1, 3